U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
136648136648Study of Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITPCompletedNo Results AvailableImmune Thrombocytopenic PurpuraDrug: Rituxan and Cyclophosphamide, Vincristine and Prednisone|Drug: Higher Dose of Rituximabhttps://ClinicalTrials.gov/show/NCT00774202
136649136649Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting ConditionsCompletedNo Results AvailableHealthyDrug: clarithromycin 250 mg tabletshttps://ClinicalTrials.gov/show/NCT00774189
136650136650Pennsylvania Study Of Chronic Obstructive Pulmonary ExacerbationsCompletedNo Results AvailableChronic Obstructive Pulmonary Diseasehttps://ClinicalTrials.gov/show/NCT00774176
136621136621PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF)CompletedNo Results AvailableAtrial FibrillationProcedure: PV-Isolation RF|Procedure: PV-Isolation Cryohttps://ClinicalTrials.gov/show/NCT00774566
136622136622To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of MetforminCompletedNo Results AvailableType 2 DiabetesDrug: AZD1656|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00774553
136623136623Acute Pain and Inflammation After SurgeryCompletedNo Results AvailableKnee InjuriesDrug: 1 Ketorolac intraarticular|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00774540
136624136624Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCTCompletedNo Results AvailableBone Marrow Failure SyndromesDrug: Cyclophosphamide-fludarabine-anti thymocyte globulinhttps://ClinicalTrials.gov/show/NCT00774527
136625136625The Cardiovascular Effects of Nitrogen Dioxide ExposureCompletedNo Results AvailableEndothelial DysfunctionProcedure: Forearm Vascular Studyhttps://ClinicalTrials.gov/show/NCT00774514
136626136626The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During RadiotherapyActive, not recruitingNo Results AvailableLiver CancerProcedure: image guidance with general anesthesia and suspended ventilation during treatment deliveryhttps://ClinicalTrials.gov/show/NCT00774501
136627136627Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose TissueCompletedNo Results AvailableMetabolic Syndrome|Obesity|Insulin SensitivityOther: Glucose dependent insulinotropic polypeptide (GIP)https://ClinicalTrials.gov/show/NCT00774488
136628136628Dual Antiplatelet Therapy Tailored on the Extent of Platelet InhibitionNot yet recruitingNo Results AvailableUnstable Angina|NSTEMIDrug: comparison of different dosage of clopidogrel|Drug: doubled therapyhttps://ClinicalTrials.gov/show/NCT00774475
136629136629Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia GravisCompletedNo Results AvailableMyositis|Myasthenia GravisDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00774462
136630136630Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung TransplantationRecruitingNo Results AvailableLung Transplantation|Bronchiolitis Obliterans Syndromehttps://ClinicalTrials.gov/show/NCT00774449
136631136631Study of Focal Cryoablation in Low-Risk Prostate CancerActive, not recruitingNo Results AvailableProstate CancerProcedure: focal cryotherapyhttps://ClinicalTrials.gov/show/NCT00774436
136632136632Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)CompletedNo Results AvailableSMADrug: Riluzolehttps://ClinicalTrials.gov/show/NCT00774423
136633136633Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)CompletedNo Results AvailableHepatitis C, ChronicDrug: BI 201335 NA 240 mg QD / LI|Drug: PegIFN/RBV|Drug: BI 201335 NA 120mg QD / LI|Drug: PegIFN/RBV|Drug: BI 201335 NA 240 mg QD|Drug: PegIFN/RBV|Drug: BI 201335 NA 240 mg QD|Drug: PegIFN/RBV|Drug: BI 201335 NA 240 mg BID|Drug: PegIFN/RBV|Drug: PegIFN/RBV|Drug: BI 201335 NA 240 mg QD|Drug: PegIFN/RBV|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00774397
136634136634Regulation of Mucosal Immune Response to Systemic MenB VaccineRecruitingNo Results AvailableMeningococcal InfectionsBiological: NZ MenB OMV vaccine (NZ98/254)https://ClinicalTrials.gov/show/NCT00774384
136635136635Weight Reduction Intervention for Breast Cancer SurvivorsCompletedNo Results AvailableBreast CancerBehavioral: Cognitive behavioral therapy CBT) for weight losshttps://ClinicalTrials.gov/show/NCT00774371
136636136636Interleukin-2 Treatment for Wiskott-Aldrich SyndromeRecruitingNo Results AvailableWiskott-Aldrich Syndrome (WAS)|X-linked ThrombocytopeniaDrug: Interleukin-2https://ClinicalTrials.gov/show/NCT00774358
136637136637A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line TherapyRecruitingNo Results AvailableB-cell Chronic Lymphocytic LeukemiaDrug: Lenalidomide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00774345
136638136638A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALLRecruitingNo Results AvailableAcute Lymphoblastic LeukemiaDrug: CODOX-Mhttps://ClinicalTrials.gov/show/NCT00774332
136639136639TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck CancerRecruitingNo Results AvailableHead and Neck CancerRadiation: conventional radiotherapy with 'high' dose cisplatin|Radiation: accelerated radiotherapy with 'low' dose cisplatinhttps://ClinicalTrials.gov/show/NCT00774319
136640136640Antiepileptic Drugs and Vascular Risk MarkersTerminatedHas ResultsSubarachnoid HemorrhageDrug: phenytoin|Drug: valproate|Drug: levetiracetamhttps://ClinicalTrials.gov/show/NCT00774306
136641136641Homoeopathic Association in Aortic Valve SurgeryCompletedNo Results AvailableAortic Valve ReplacementDrug: placebo|Drug: Arnica and Bryoniahttps://ClinicalTrials.gov/show/NCT00774293
136642136642Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning RegimenCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromeDrug: BuCy vs BuFluhttps://ClinicalTrials.gov/show/NCT00774280
136643136643Study Evaluating Changes In Mammographic Breast DensityCompletedHas ResultsOsteoporosisDrug: BZA 20 mg/CE 0.45 mg|Drug: BZA 20 mg/CE 0.625 mg|Drug: Raloxifene 60 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00774267
136644136644Reactions to Disease Risk InformationCompletedNo Results AvailableCancerhttps://ClinicalTrials.gov/show/NCT00774254
136645136645PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast CancerWithdrawnNo Results AvailableBreast CancerDrug: bevacizumab [Avastin]|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00774241
136646136646I-ZIP Ocular Bandage Pivotal StudyCompletedNo Results AvailableCataractDevice: I-ZIP Ocular Bandage|Device: Oasis 24 Hour Soft Shield Collagen Corneal Shieldhttps://ClinicalTrials.gov/show/NCT00774228
136647136647Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 YearCompletedNo Results AvailablePelvic Organ Prolapsehttps://ClinicalTrials.gov/show/NCT00774215

* Görseller ve İçerik tekif hakkına sahip olabilir